2 results
Approved WMOCompleted
The primary objective is to determine the effectiveness of RSWT versus FSWT in treating patellar tendinopathy.
Approved WMOCompleted
To characterize the safety, tolerability, and recommended phase 2 dose (RP2D) of each combination partner used with ruxolitinib (Part 1)To evaluate the preliminary efficacy of each novel ruxolitinib combination treatment arm (Parts 2 & 3)